171 related articles for article (PubMed ID: 30694934)
1. Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort Study.
Sotimehin AE; Patel HD; Alam R; Gorin MA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2019 May; 201(5):886-892. PubMed ID: 30694934
[TBL] [Abstract][Full Text] [Related]
2. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
3. A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention.
Patel HD; Riffon MF; Joice GA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Trock BJ; Allaf ME; Pierorazio PM
J Urol; 2016 Nov; 196(5):1356-1362. PubMed ID: 27140071
[TBL] [Abstract][Full Text] [Related]
4. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
Uzosike AC; Patel HD; Alam R; Schwen ZR; Gupta M; Gorin MA; Johnson MH; Gausepohl H; Riffon MF; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2018 Mar; 199(3):641-648. PubMed ID: 28951284
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
Danzig MR; Ghandour RA; Chang P; Wagner AA; Pierorazio PM; Allaf ME; McKiernan JM
J Urol; 2015 Oct; 194(4):903-9. PubMed ID: 25813449
[TBL] [Abstract][Full Text] [Related]
7. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
McIntosh AG; Ristau BT; Ruth K; Jennings R; Ross E; Smaldone MC; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG
Eur Urol; 2018 Aug; 74(2):157-164. PubMed ID: 29625756
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?
Ambani SN; Morgan TM; Montgomery JS; Gadzinski AJ; Jacobs BL; Hawken S; Krishnan N; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Palapattu GS; Weizer AZ; Wolf JS
Urology; 2016 Dec; 98():88-96. PubMed ID: 27450936
[TBL] [Abstract][Full Text] [Related]
9. Management of Renal Masses in an Octogenarian Cohort: Is There a Right Approach?
Tang DH; Nawlo J; Chipollini J; Gilbert SM; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
Clin Genitourin Cancer; 2017 Dec; 15(6):696-703. PubMed ID: 28566202
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry.
Metcalf MR; Cheaib JG; Biles MJ; Patel HD; Peña VN; Chang P; Wagner AA; McKiernan JM; Pierorazio PM
J Urol; 2021 May; 205(5):1286-1293. PubMed ID: 33356478
[TBL] [Abstract][Full Text] [Related]
11. The natural history of renal functional decline in patients undergoing surveillance in the DISSRM registry.
Castañeda CV; Danzig MR; Finkelstein JB; RoyChoudhury A; Wagner AA; Chang P; Pierorazio PM; Allaf ME; McKiernan JM
Urol Oncol; 2015 Apr; 33(4):166.e17-20. PubMed ID: 25601768
[TBL] [Abstract][Full Text] [Related]
12. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract][Full Text] [Related]
13. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.
Shah PH; Alom MA; Leibovich BC; Thompson RH; Uzzo RG; Kavoussi LR; Richstone L; Bhindi B; Habermann EB; Joshi V; Boorjian SA
J Urol; 2018 Nov; 200(5):981-988. PubMed ID: 29792881
[TBL] [Abstract][Full Text] [Related]
14. Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study.
Whelan EA; Mason RJ; Himmelman JG; Matheson K; Rendon RA
J Urol; 2019 Jul; 202(1):57-61. PubMed ID: 30932757
[TBL] [Abstract][Full Text] [Related]
15. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis.
Dorin R; Jackson M; Cusano A; Haddock P; Kiziloz H; Meraney A; Shichman S
Int Braz J Urol; 2014; 40(5):627-36. PubMed ID: 25498286
[TBL] [Abstract][Full Text] [Related]
17. Active Surveillance for Favorable Risk Prostate Cancer in African Caribbean Men: Results of a Prospective Study.
Meunier ME; Eyraud R; Sénéchal C; Gourtaud G; Roux V; Lanchon C; Brureau L; Blanchet P
J Urol; 2017 May; 197(5):1229-1236. PubMed ID: 27993665
[TBL] [Abstract][Full Text] [Related]
18. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.
Mehrazin R; Smaldone MC; Kutikov A; Li T; Tomaszewski JJ; Canter DJ; Viterbo R; Greenberg RE; Chen DY; Uzzo RG
J Urol; 2014 Sep; 192(3):659-64. PubMed ID: 24641909
[TBL] [Abstract][Full Text] [Related]
19. Conditional survival of patients with small renal masses undergoing active surveillance.
Petros FG; Venkatesan AM; Kaya D; Ng CS; Fellman BM; Karam JA; Wood CG; Matin SF
BJU Int; 2019 Mar; 123(3):447-455. PubMed ID: 30007044
[TBL] [Abstract][Full Text] [Related]
20. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
